Literature DB >> 22906740

IgA plasma cells express the negative regulatory co-stimulatory molecule programmed cell death 1 ligand and have a potential tolerogenic role in the intestine.

Tomomitsu Doi1, Takanori Kanai, Yohei Mikami, Tomohisa Sujino, Li Jun, Yuichi Ono, Atsushi Hayashi, Toshifumi Hibi.   

Abstract

To maintain immune homeostasis in the intestine, the intestinal immune system has evolved several tolerogenic mechanisms toward intestinal microflora and food antigens. Although programmed cell death-1 (PD-1) protein has been implicated in immunological tolerance in the intestine and gut-associated lymphoid tissues (GALTs), distribution of its ligands PD-L1 and PD-L2 in the small intestine lamina propria (LP) are unknown. We investigated PD-L1 expression in intestinal LP and found that IgA plasma cells (PCs) were major PD-L1 expressing cells. PD-L1 expression levels on IgA PCs were higher than that on IgG PCs in peripheral lymphoid tissues. IgA PCs expressed antigen-presenting molecule MHC class II and co-stimulatory molecules CD80, CD86, and PD-L2. IgA PCs isolated from intestinal LP exhibited antigen presentation activity, and in the presence of TGF-β induced FoxP3(+) regulatory T cells, but not IFN-γ(+) Th1 cells, from naïve T cells. Thus, IgA PCs in the intestine may be involved in an immune regulatory role in the intestinal immune system.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22906740     DOI: 10.1016/j.bbrc.2012.08.010

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  Plasma cells in primary melanoma. Prognostic significance and possible role of IgA.

Authors:  Francesca M Bosisio; James S Wilmott; Nathalie Volders; Marjorie Mercier; Jasper Wouters; Marguerite Stas; Willeke Am Blokx; Daniela Massi; John F Thompson; Richard A Scolyer; Nicolas van Baren; Joost J van den Oord
Journal:  Mod Pathol       Date:  2016-02-12       Impact factor: 7.842

2.  Isotype-specific plasma cells express divergent transcriptional programs.

Authors:  Brett W Higgins; Andrew G Shuparski; Karen B Miller; Amanda M Robinson; Louise J McHeyzer-Williams; Michael G McHeyzer-Williams
Journal:  Proc Natl Acad Sci U S A       Date:  2022-06-15       Impact factor: 12.779

3.  Extrafollicular Plasmablasts Present in the Acute Phase of Infections Express High Levels of PD-L1 and Are Able to Limit T Cell Response.

Authors:  Melisa Gorosito Serrán; Facundo Fiocca Vernengo; Laura Almada; Cristian G Beccaria; Yamila Gazzoni; Pablo F Canete; Jonathan A Roco; Jimena Tosello Boari; Maria Cecilia Ramello; Ellen Wehrens; Yeping Cai; Elina I Zuniga; Carolina L Montes; Ian A Cockburn; Eva V Acosta Rodriguez; Carola G Vinuesa; Adriana Gruppi
Journal:  Front Immunol       Date:  2022-05-16       Impact factor: 8.786

Review 4.  Immunosuppressive Mechanisms of Regulatory B Cells.

Authors:  Diego Catalán; Miguel Andrés Mansilla; Ashley Ferrier; Lilian Soto; Kristine Oleinika; Juan Carlos Aguillón; Octavio Aravena
Journal:  Front Immunol       Date:  2021-04-29       Impact factor: 7.561

5.  Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy.

Authors:  Shabnam Shalapour; Joan Font-Burgada; Giuseppe Di Caro; Zhenyu Zhong; Elsa Sanchez-Lopez; Debanjan Dhar; Gerald Willimsky; Massimo Ammirante; Amy Strasner; Donna E Hansel; Christina Jamieson; Christopher J Kane; Tobias Klatte; Peter Birner; Lukas Kenner; Michael Karin
Journal:  Nature       Date:  2015-04-29       Impact factor: 49.962

6.  Molecular signatures of the evolving immune response in mice following a Bordetella pertussis infection.

Authors:  René H M Raeven; Jolanda Brummelman; Jeroen L A Pennings; Olaf E M Nijst; Betsy Kuipers; Laura E R Blok; Kina Helm; Elly van Riet; Wim Jiskoot; Cecile A C M van Els; Wanda G H Han; Gideon F A Kersten; Bernard Metz
Journal:  PLoS One       Date:  2014-08-19       Impact factor: 3.240

Review 7.  Tertiary Lymphoid Structures: An Anti-tumor School for Adaptive Immune Cells and an Antibody Factory to Fight Cancer?

Authors:  Jean-Luc Teillaud; Marie-Caroline Dieu-Nosjean
Journal:  Front Immunol       Date:  2017-07-21       Impact factor: 7.561

Review 8.  Beyond Cancer: Regulation and Function of PD-L1 in Health and Immune-Related Diseases.

Authors:  Amke C Beenen; Tatjana Sauerer; Niels Schaft; Jan Dörrie
Journal:  Int J Mol Sci       Date:  2022-08-02       Impact factor: 6.208

9.  Mild photothermal therapy potentiates anti-PD-L1 treatment for immunologically cold tumors via an all-in-one and all-in-control strategy.

Authors:  Liping Huang; Yanan Li; Yunai Du; Yiyi Zhang; Xiuxia Wang; Yuan Ding; Xiangliang Yang; Fanling Meng; Jiasheng Tu; Liang Luo; Chunmeng Sun
Journal:  Nat Commun       Date:  2019-10-25       Impact factor: 14.919

10.  Coordinated co-migration of CCR10+ antibody-producing B cells with helper T cells for colonic homeostatic regulation.

Authors:  Luming Zhao; Shaomin Hu; Micha L Davila; Jie Yang; Yang-Ding Lin; Joseph M Albanese; Yungtai Lo; Yanhua Wang; Mary J Kennett; Qiang Liu; Na Xiong
Journal:  Mucosal Immunol       Date:  2020-08-09       Impact factor: 7.313

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.